Endothelin B receptor drug reduces memory loss, oxidative stress in Alzheimer's disease
An estimated 5.3 million people in the U.S. suffer from Alzheimer's disease (AD)—the most common form of dementia—and roughly 473,000 people will develop the disease in 2015. There are currently five medications approved ...
Sep 7, 2015
0
17